The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Live Science on MSN23h
FDA approves 1st new class of opioid-free painkillers in over 20 yearsThe FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Verywell Health on MSN21h
New FDA-Approved Painkiller Is a Safer Alternative to OpioidsThe FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback